William Wilcox

Contact Information:

Email: william.wilcox@emory.edu

View Emory directory entry

School/Division:

Professor

SOM: Hum Gen: Admin

School Of Medicine

Other Affiliations:

No affiliations have been saved.

External Links (e.g. Departmental web site, iTunes lectures, etc.):

No external links have been saved.

Degrees Held:

No degrees have been saved.

Research Interests:

No research interests have been saved.

Biography/Description of Research:

No biography information has been saved.

Works 1-10 of 15

  1. 1
  2. 2

Article

Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease

by Dominique P. Germain; Joel Charrow; Robert J. Desnick; Nathalie Guffon; Judy Kempf; Robin H. Lachmann; Roberta Lemay; Gabor E. Linthorst; Seymour Packman; C. Ronald Scott; Stephen Waldek; David G. Warnock; Neal J. Weinreb; William Wilcox

2015

Article

Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study

by Derralynn A Hughes; Kathleen Nicholls; Suma Shankar; Gere Sunder-Plassmann; David Koeller; Khan Nedd; Gerard Vockley; Takashi Hamazaki; Robin Lachmann; Toya Ohashi; Iacopo Olivotto; Norio Sakai; Patrick Deegan; David Dimmock; François Eyskens; Dominique P. Germain; Ozlem Goker-Alpan; Eric Hachulla; Ana Jovanovic; Charles M Lourenco; Ichiei Narita; William Wilcox

2017

Article

A Novel ZRS Mutation Leads to Preaxial Polydactyly Type 2 in a Heterozygous Form and Werner Mesomelic Syndrome in a Homozygous Form

by Julia E. VanderMeer; Reymundo Lozano; Miao Sun; Yuan Xue; Donna Daentl; Ethylin Wang Jabs; William R. Wilcox; Nadav Ahituv

2014

Article

FGFR3 mutation frequency in 324 cases from the International Skeletal Dysplasia Registry

by Yuan Xue; Angela Sun; P Betty Mekikian; Jorge Martin; David L Rimoin; Ralph S Lachman; William Wilcox

2014

Article

Antiproteinuric therapy and Fabry nephropathy: factors associated with preserved kidney function during agalsidase-beta therapy

by David G Warnock; Christie P Thomas; Bojan Vujkovac; Ruth C Campbell; Joel Charrow; Dawn Laney; Leslie L Jackson; William Wilcox; Christoph Wanner

2015

Article

Analysis of STAT1 Activation by Six FGFR3 Mutants Associated with Skeletal Dysplasia Undermines Dominant Role of STAT1 in FGFR3 Signaling in Cartilage

by Pavel Krejci; Lisa Salazar; Tamara A. Kashiwada; Katarina Chlebova; Alena Salasova; Leslie Michels Thompson; Vitezslav Bryja; Alois Kozubik; William R. Wilcox

2008

Article

Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy

by Raphael Schiffmann; David G. Warnock; Maryam Banikazemi; Jan Bultas; Gabor E. Linthorst; Seymour Packman; Sven Asger Sorensen; William R. Wilcox; Robert J. Desnick

2009